Ankylosis - 220 Studies Found
| Completed |
: Study of the Safety and Efficacy of Golimumab in Chinese Patients With Ankylosing Spondylitis : Ankylosing Spondylitis : 2010-11-24 :
|
| Completed |
: Program evaLuating the Autoimmune Disease iNvEstigational Drug cT-p13 in AS Patients(PLANETAS) : Ankylosing Spondylitis : 2010-10-04 : Drug: Infliximab Infliximab 5mg/kg is going to be administered for both arm as a 2-hour infusion per dos |
| Completed |
: Effect of Anti-TNF (Alpha) Treatment on Vascular Stiffness in Ankylosing Spondylitis (AS) : Ankylosing Spondylitis(AS) : 2010-09-30 :
|
| Terminated |
: A Study of RoActemra/Actemra (Tocilizumab) in Patients With Ankylosing Spondylitis Who Have Failed Treatment With NSAIDs : Spondylitis, Ankylosing : 2010-09-24 :
|
| Terminated |
: A Study of Tocilizumab (RoActemra/Actemra) in Patients With Ankylosing Spondylitis Who Have Had an Inadequate Response to Previous Tumor Necrosis Factor (TNF) Antagonist Therapy : Spondylitis, Ankylosing : 2010-09-24 :
|
| Completed |
: Intestinal Inflammation in Ankylosing Spondylitis and the Effects of Adalimumab on Mucosal Healing :
: 2010-07-16 : Drug: Adalimumab Tumor Necrosis Factor (TNF) alpha inhibitor given 40 mg subcutaneously every other week |
| Terminated |
: Extension Study for Long Term Evaluation of SAR153191 (REGN88) in Patients With Ankylosing Spondylitis : Ankylosing Spondylitis : 2010-05-05 : Drug: Sarilumab Pharmaceutical form: solution for injectio |
| Completed |
: Efficacy and Safety of Adalimumab in Adult Chinese Subjects With Active Ankylosing Spondylitis : Ankylosing Spondylitis : 2010-02-05 :
|
| Completed |
: Safety and Tolerability of AIN457 in Adults (18-65 Years) With Moderate to Severe Ankylosing Spondylitis : Ankylosing Spondylitis : 2010-04-22 : Biological: AIN457A |
| Completed |
: Assessment of the Response to Etoricoxib in Patients With Ankylosing Spondylitis and Inadequate Response to ≥2 NSAIDs : Ankylosing Spondylitis : 2010-03-22 : Drug: Etoricoxib Etoricoxib 90 mg/day/PO during 4 weeks Positive response to the therapy (in investigato |